Table 4.
Models with Akaike weights (wi) > 0 and ΔAICc < 10, modelling faecal glucocorticoid metabolite concentrations in horses
| Model: log(FGM) ~ | logL | K | AICc | Δ | w i |
|---|---|---|---|---|---|
| days + duration + discharge + EHV-4 + pyrexia + (1|farm) + (1|horse) | −364.6 | 9 | 747.8 | 0.0 | 0.48 |
| days + duration + discharge + EHV-4 + (1|farm) + (1|horse) | −366.5 | 8 | 749.5 | 1.7 | 0.21 |
| days + duration + discharge + EHV-4 + pyrexia + auction + (1|farm) + (1|horse) | −364.4 | 10 | 749.5 | 1.7 | 0.21 |
| days + duration + discharge + EHV-4 + auction + (1|farm) + (1|horse) | −366.4 | 9 | 751.2 | 3.5 | 0.08 |
| days + discharge + EHV-4 + pyrexia + (1|farm) + (1|horse) | −369.6 | 8 | 755.5 | 7.7 | 0.01 |
| days + discharge + EHV-4 + pyrexia + auction + (1|farm) + (1|horse) | −369.2 | 9 | 756.9 | 9.1 | 0.01 |
Individual horses (1|horse) and farms (1|farm) were random effects in all models. Fixed effects were days post arrival (days), auction phase (auction), duration of transport (duration), pyrexia, nasal discharge (discharge), and EHV-4 DNA detection
FGM, faecal glucocorticoid metabolites; EHV-4, equine herpesvirus-4